Pacira Pharmaceuticals, Inc. (US:PCRX) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds (or held) more than 5% of the PCRX: Pacira BioSciences Inc - Options Chain - Zacks.com PCRX: Pacira BioSciences Inc options chain stock quote. Get the latest options chain stock quote information from Zacks Investment Research. PCRX: Pacira BioSciences Inc - Zacks Investment Research PCRX: Pacira BioSciences Inc income statement. Get the latest income statement from Zacks Investment Research. PCRX: Pacira BioSciences Inc - Full Company Report - Zacks.com
Catalyst Pharmaceutical Partners Inc. - Stocktwits Catalyst Pharmaceutical Partners Inc. CPRX 4.53 0.05 (1.03%). NASDAQ Updated Jun 8, 2020 11:54 PM Stocktwits - The largest community for investors and traders Join Stocktwits for free stock discussions, prices, and market sentiment with millions of investors and traders. Stocktwits is the largest social network for finance.
PCRX Stock Price and Chart — NASDAQ:PCRX — TradingView Pacira Biosciences, Inc. develops and manufactures injectable therapeutic products. The firm engages in the development, commercialization and manufacture of pharmaceutical products for use in postsurgical outcomes for acute care practitioners and their patients. PCRX - Pacira Pharmaceuticals, Inc. Summary, Stock Quote ... Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and Pacira BioSciences, Inc. (PCRX) Stock Historical Prices ... Discover historical prices for PCRX stock on Yahoo Finance. View daily, weekly or monthly format back to when Pacira BioSciences, Inc. stock was issued.
PCRX - Pacira Pharmaceuticals, Inc. Summary, Stock Quote ... Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and Pacira BioSciences, Inc. (PCRX) Stock Historical Prices ... Discover historical prices for PCRX stock on Yahoo Finance. View daily, weekly or monthly format back to when Pacira BioSciences, Inc. stock was issued.
Description: Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for health care practitioners and their patients. The company has launched EXPAREL which utilizes DepoFoam, a product delivery technology that encapsulates drugs without altering their Catalyst Pharmaceuticals, Inc. Common Stock (CPRX) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! Firdapse Spinal Muscular Atrophy (SMA) Type 3 **** Phase 2 data due 1H 2020 Firdapse MuSK-antibody positive myasthenia gravis (MuSK-MG) **** Phase 3 data due 1H 2020 Short Float = 13.23% Broke out of triangle, looking for a small pullback to the cloud / support line, have a stop under suport line at 4.20 and Target at 7.50 for at possible 70% upside SRNE | Complete Sorrento Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.